8 results
Pulmonary Infections in HIV-AIDS
Bacterial: 
 • No organism identified, Strep pneumoniae, H. influenzae, S.aureus, Streptococcus Grp
Pulmonary Infections ... failure, COPD, Lung cancer ... in particular) Evaluation ... Infections #HIVAIDS #workup ... #diagnosis #evaluation
Diarrhea Workup and Management Algorithm in Transplant Patients
First Tier Microbiologic-Testing:
1. C. difficile PCR (Stool)
2. CMV qPCR
Diarrhea Workup ... and Management Algorithm ... Ova and Parasite evaluation ... *Especially if concern ... #Transplant #diagnosis
Evaluation and Management of Hyperkalemia

As with hypokalemia, the immediate danger of hyperkalemia is its effect on
the immediate danger ... its effect on cardiac ... The absence of symptoms ... #Diagnosis #Hyperkalemia ... #Evaluation #Algorithm
â–º
ISCHEMIA Trial - Management Algorithm for patients with Stable Angina

Stress Test -> ? +moderate or severe
LMCA lesion -> Cardiac ... revascularization (PCI ... with a stable symptom ... syndrome (ACS) evaluation ... Angina #ChestPain #Diagnosis
UCSF COVID-19 Adult Clinical Evaluation Guide - Updated April 10 2020

Clinical Presentation
• Fever: hospitalized pts but
Adult Clinical Evaluation ... 3-12% • Cardiac ... incr in 27-75% • PCT ... #Guide #Diagnosis ... #Algorithm #Protocol
Pulmonary Renal Syndromes - OnePager Summary
Autoimmune ANCA vasculitis (AAV): GPA (granulomatous with polyangiitis), EGPA (eosinophilic granulomatosis
nose deformity • Cardiac ... mononeuritis multiplex WORKUP ... (UPC) ratio • Cardiac ... BNP, troponin if concern ... or serologies + symptoms
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Preoperative Risk Evaluation ... murmur 3/6) - Pulmonary ... exam Determine Cardiac ... event, follow ACC algorithm ... stratification #diagnosis
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... risk of clonal evolution ... disease-associated symptoms ... median age at diagnosis ... cardiovascular or pulmonary